We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+5.06%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$855M
AUM Growth
+$22.3M
Cap. Flow
-$9.36M
Cap. Flow %
-1.09%
Top 10 Hldgs %
23.41%
Holding
277
New
6
Increased
100
Reduced
118
Closed
9

Top Buys

Rank Stock Value
1
FTV icon
Fortive
FTV
+$873K
2
EVH icon
Evolent Health
EVH
+$468K
3
DELL icon
Dell
DELL
+$446K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$267K
5
BEN icon
Franklin Templeton
BEN
+$206K

Top Sells

Rank Stock Value
1
EMC
EMC CORPORATION
EMC
+$2.52M
2
RS icon
Reliance Steel & Aluminium
RS
+$946K
3
DHR icon
Danaher
DHR
+$838K
4
IWC icon
iShares Micro-Cap ETF
IWC
+$766K
5
MZTI
The Marzetti Company
MZTI
+$676K

Sector Composition

Rank Sector Weight
1 Miscellaneous 21.14%
2 Healthcare 14.13%
3 Consumer Staples 13.75%
4 Technology 11.54%
5 Financials 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BEN icon
251
Franklin Templeton
BEN
$17.6B
$207K 0.02%
+5,818
New +$206K
NVS icon
252
Novartis
NVS
$292B
$203K 0.02%
2,875
-202
-7% -$14.7K
TNDM icon
253
Tandem Diabetes Care
TNDM
$1.49B
$135K 0.02%
1,757
– –
DYSL
254
DELISTED
Dynasil Corporation of America
DYSL
$124K 0.01%
125,064
+2,934
+2% +$3.56K
LQMT
255
DELISTED
LIQUIDMETAL TECHNOLOGIES INC
LQMT
$33K ﹤0.01%
213,000
– –
ATNM icon
256
Actinium Pharmaceuticals
ATNM
$31.7M
$31K ﹤0.01%
762
– –
TRNX
257
DELISTED
Taronis Technologies, Inc. Common Stock
TRNX
$7K ﹤0.01%
+1
New +$9.32K
LINE
258
DELISTED
LINN ENERGY LLC COM UTS REP LTD LIABILITY CO INTS
LINE
$1K ﹤0.01%
11,875
– –
CHTR icon
259
Charter Communications
CHTR
$18.3B
– –
-911
Closed -$208K
IBKR icon
260
Interactive Brokers
IBKR
$43.4B
– –
-60,400
Closed -$535K
NSIT icon
261
Insight Enterprises
NSIT
$4.57B
– –
-10,194
Closed -$265K
RTN
262
DELISTED
Raytheon Company
RTN
– –
-1,492
Closed -$203K
EMC
263
DELISTED
EMC CORPORATION
EMC
– –
-92,937
Closed -$2.52M
GNBT
264
DELISTED
GENEREX BIOTECHNOLOGY CORP
GNBT
– –
-21,000
Closed –
TYC
265
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
– –
-6,764
Closed -$302K
OREX
266
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-68,381
Closed -$294K
7 8 9 10
11

Similar funds

AC
Alleghany Corporation New York $2.21B AUM 10.5% 1-Year Est. Return
CCM
Covington Capital Management Los Angeles, California $2.32B AUM 12.18% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
APA
American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
SCA
Salient Capital Advisors Houston, Texas $1.74B AUM 12.95% 1-Year Est. Return
ACM
AlphaCrest Capital Management New York $1.64B AUM 23.4% 1-Year Est. Return
W
Wealthsimple Toronto, Ontario, Canada $2.69B AUM 18.39% 1-Year Est. Return

Dowling & Yahnke's Q3 2016 Portfolio in Review

As of Q3 2016, Dowling & Yahnke held 277 positions worth $855M, up 2.7% from $833M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Dowling & Yahnke's Q3 2016 filing shows 6 new, 100 increased, 118 reduced and 9 closed positions. Its largest new stake was Fortive: 27,196 shares worth $873K. The largest sale was EMC CORPORATION, an estimated $2.52M.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dowling & Yahnke's largest Q3 2016 buy was Fortive: 27,196 shares worth $873K.
  • Dowling & Yahnke added most to Evolent Health in Q3 2016, an estimated $468K increase.
  • Dowling & Yahnke's biggest Q3 2016 reduction was Reliance Steel & Aluminium, cutting an estimated $946K.
  • Dowling & Yahnke fully exited EMC CORPORATION in Q3 2016, selling an estimated $2.52M.
  • Dowling & Yahnke's ten largest holdings make up 23% of its $855M portfolio in Q3 2016.
  • Dowling & Yahnke opened 6 new positions and closed 9 in Q3 2016.
  • Dowling & Yahnke's portfolio value rose 2.7% quarter-over-quarter to $855M.

Based on Dowling & Yahnke's 13F filing for Q3 2016, filed 20 Oct 2016.